This page contains a Flash digital edition of a book.
Introduce a colleague to membership in ISTH! •

ISTH and its activities around the world greatly depend on the active involvement of our members and the network of members around the world.

We invite your help and support as members of the Society to further expand ISTH’s initiatives, international community, reach and impact.

ISTH membership is of great value for researchers, clinicians, and medical professionals at all stages of their career. We encourage you to share the ISTH membership benefits with your colleagues and particularly highlight the 3 categories of membership:

Regular: for fulltime professionals with a continuing scientific interest in thrombosis, hemostasis and vascular biology,

Associate: students, trainees, postdocs, and nurses,

• Reach the World: researchers, educators and clinicians from

the developing world.

ISTH membership offers very concrete benefits such as a personal subscription to JTH as well as opportunities for global networking and professional development. For more detailed information on each membership level, please visit the ISTH website ( and click on the “Membership” link.

2011 Mannucci Award Winners announced

The Mannucci Prizes are awarded in honor of Pier M. Mannucci, the first Editor-in-Chief of the Journal of Thrombosis and Haemostasis, for the best articles by Investigators younger than 35 years of age. The prizes are made possible by a generous contribution from Bayer HealthCare, and recipients are selected by a jury of editors. We congratulate the 2011 winners:

Jonas Bjerring Olesen, Copenhagen, Denmark: Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. (

Morten Schmidt, Aarhus, Denmark: Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. (

Firdos Ahmad, Philadelphia, PA, USA: Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. (

Maarten Louis Veronique Hendrickx, Leuven, Belgium:

TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation. (

Christian Schulz, London, UK: EMMPRIN (CD147/basigin) mediates platelet–monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. (

Wendy Zondag, Delfgauw, The Netherlands: Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. (


JOIN NOW CLICK HERE ( | June 2012 | 7


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12
Produced with Yudu -